Moderated by Onyinye Esenwa & Raina Kim

• Beyond Access: Advancing Black Health Equity in Gastroenterology with OmiSoore Dryden
• Can We Address EDIRA in Gastroenterology? with Cynthia Seow
• Equitable care in diverse patient populations with Eytan Wine
• Why you should see (or be) a female gastroenterologist with Laura Targownik

Introductory remarks by Premysl Bercik & Carolina Tropini

• ABSTRACT: Helminth-Induced IL-33 Promotes Tissue-Repair Macrophages That Protect Against Colitis Independent if IL-4 Signaling with Lucas Kraemer
• ABSTRACT: Escherichia Coli Pathobionts Isolated from Ulcerative Colitis Patients Harbour Numerous Proteins that Degrade Human Colonic Mucus with Ashley Gilliland
• ABSTRACT: Exploring the Effects of Commonly Used Artificial Food Colourants in the Pathogenesis of Colitis with Tyler Seto
• ABSTRACT: Carboxymethylcellulose Sensitive Gut Microbiome Signatures and their Immuno-Metabolomic Links to Crohn's Disease with Jeongseok Kim
• ABSTRACT: Maternal IBD-Associated Microbiota Shapes Immune System in Offspring with Xavier Mas Orea
• ABSTRACT: Glycocaging Improves the Therapeutic Index of IBD Drugs with Wei Jen Ma

Moderated by Heiko Pohl and Nauzer Forbes 

Featuring Natalia Calo, Sunil Gupta, Gary May, Jeff Mosko, and Christopher Teshima

This workshop offers participants a practical and accessible introduction to intestinal ultrasonography (IUS), an increasingly valuable tool in the real-time assessment and management of inflammatory bowel disease. Attendees will build a strong foundational understanding of IUS principles, image acquisition, and interpretation, while gaining insight into how this modality enhances clinical decision-making in Crohn’s disease and ulcerative colitis. Through focused instruction and applied learning, the session equips clinicians with the knowledge to integrate IUS into routine practice, improving disease monitoring, patient engagement, and overall quality of care.

Moderated by Yasmin Nasser & Vivian Huang

• ABSTRACTS: Crohn Disease Exclusion Diet Maintenance Therapy Induces Sustained Microbiome Changes with Anissa Armet
• ABSTRACTS: Non-Invasive Peptidomic Signature Distinguishing Active and Remissive IBD Using a Nested Cross-Validated Machine-Learning Study with Elmira Shajari
• ABSTRACTS: The Use of HLADQA1*05G>A Screening for the Selection of Non-Tumor Necrosis Factor-Alpha Antagonist Advanced Therapies in Inflammatory Bowel Disease: A Prospective Study with Virginia Guisandes Bueno
• ABSTRACTS: Time-Trajectory Analysis of Proteomics Reveals Potential Pre-Clinical Stages of Crohn's Disease with Rirong Chen
• ABSTRACTS: Wait Times for Colonoscopy According to Subsequent Pathology to Improve a Colonoscopy Referral Sheet with Alan Barkun
• ABSTRACTS: Impact of CADX on Optical Diagnosis of Serrated and Advanced Colorectal Lesions: A Prospective Implementation Study with Megan Oleksiw

Moderated by Heiko Pohl and Nauzer Forbes 

Featuring Natalia Calo, Yen-I Chen, Gary May, and Sunil Gupta

Moderated by Fernand Pierre Gendron and Laura Sly

• Live bacterial therapeutics for detection and treatment of colorectal cancer with Amir Zarrinpar
• “Glycocaging” IBD drugs for targeted GI delivery with Laura Sly
• Culturing Colonic Organoids with a Minimal Mimetic Matrix: Because Organoids Need the Right Support! with Nathalie Perrault
• ABSTRACT: Precision Phage Therapy Mitigates Colitis and Enhances Steroid Efficacy Through Suppression of Crohn’s-Associated Bacterial Virulence with Kyle Jackson

Moderated by Alberto Caminero and Vivian Huang

• Eosinophils and adverse reactions to foods in functional dyspepsia with Tim Vanuytsel
• The role of stress in food intolerances in IBS with David Reed
• Microbial drivers of food sensitivities and adverse reactions to foods in IBD with Alberto Caminero
• ABSTRACT: Saccharomyces Boulardii Cncm I-745 Synergizes with the Small Intestinal Microbiota to Boost Ahr Signaling in Celiac Disease with Kelly Kan

Moderated by Nauzer Forbes and Frances Tse

• Malignant UGI bleeding: Moving beyond injection, cautery, and clips with Alan Barkun
• Gastric Antral Vascular Ectasia: beyond Argon Plasma Coagulation with Grigorios Leontiadis
• Dieulafoy’s and Mallory Weiss Tears: Beyond the obvious with Lawrence Hookey

Moderated by Jennifer Jones and Reena Khannah

• Real World Precision Management of IBD: Are we there yet? with Gilaad Kaplan
• Management of perianal Crohn’s disease: Beyond setons and anti TNFs with Jeff McCurdy
• Breaking through the therapeutic ceiling in IBD: Strategic Successes and Pitfalls with Michael Stewart
• Q&A

This workshop offers participants a practical and accessible introduction to intestinal ultrasonography (IUS), an increasingly valuable tool in the real-time assessment and management of inflammatory bowel disease. Attendees will build a strong foundational understanding of IUS principles, image acquisition, and interpretation, while gaining insight into how this modality enhances clinical decision-making in Crohn’s disease and ulcerative colitis. Through focused instruction and applied learning, the session equips clinicians with the knowledge to integrate IUS into routine practice, improving disease monitoring, patient engagement, and overall quality of care.

Introductory remarks by Premysl Bercik and Geoff Nguyen

• Early Research Awardee Lecture on Regulation of intestinal immune homeostasis - from animal models to patients presented by Arthur Mortha
• Research Excellence Awardee Lecture on Defining the Global Epidemiology of IBD: A Journey Fueled by Collaboration and Mentorship presented by Gilaad Kaplan
• Early Career Scholar in Quality Awardee Lecture on Bridging the Gap: Inflammatory Bowel Disease Care Among Racial and Ethnic Minorities presented by Paul Tandon
• Excellence in Quality Innovation Awardee Lecture on The Liver Landscape: A Year in Review and the Road Ahead presented by Mayur Brahmania

Moderated by Jennifer Flemming and Jordan Francheville

• The Liver Landscape: A Year in Review and the Road Ahead with Mayur Brahmania
• What’s New in Focal Liver Lesions with Tasha Kulai
• Preventing Complications in Cirrhosis with Juan Abraldes
• Gastrointestinal care after liver transplantation with Vladimir Marquez

Moderated by Narges Ashrafinia & Eric Benchimol 

• Adverse Events, Success, and Tolerability of Biliary ERCP with Conscious Sedation vs. Anesthesia: a Multi-center Prospective Study with Nauzer Forbes
• Assessing colorectal cancer screening and outcomes among First Nations people in Alberta with Lea Bill
• GLP-1 Receptor Agonists in Inflammatory Bowel Disease: Clinical, Nutritional, and Emerging Therapeutic Considerations with Alice Cheng and Joelle St.Pierre
• Panel Discussion with Cynthia Seow

Moderated by Francois Boudreau and Linda Rabeneck

• Epidemiology of Early Onset Colorectal Cancer with Jill Tinmouth
• Genotoxic bacteria in colorectal cancer development and metastasis with Christian Jobin
• Diet and Gut Microbes: Converging determinants of Colorectal Cancer development with Bhupesh Kumar Thakur

Moderated by Laura Targownik and Milli Gupta

• Gut Instincts: Women Driving Entrepreneurship in GI and Hepatology Panel with Nicky Marwaha, Maitreyi Raman, Sarah Robbins, Elena Verdu, and Talia Zenlea

Introduction and welcoming remarks by Lawrence Hookey 

Welcome ceremony and blessing with Elder Lori Lamarche Boros

Introduction of Ontario Association by Natasha Bollegala

Awards Presentation

Closing Remarks by Lawrence Hookey

Moderated by Kirk Bergstrom and Giada de Palma

• The Vascular barrier in the GI tract with Giovanni Barbara
• Immune system as the second line of defense with Andrew Macpherson
• The Potential of Glycan-Rich Gel-Forming Mucins as a Novel Therapeutic Platform for Inflammatory Bowel Disease with Kirk Bergstrom
• ABSTRACT: CX3CR1+ Myeloid Cell-Intrinsic NOD2 Signaling Limits Crohn's Disease-Associated Intestinal Fibrosis with Tapas Mukherjee

Moderated by Genelle Lunken and Maitreyi Raman

• Reframing nutrition in obesity management in the era of GLP-1–based therapies with Flavio Teixeira Vieira
• Obesity & celiac disease with Maria Ines Pinto Sanchez
• GLP-1 Receptor Agonist Therapy in Inflammatory Bowel Disease: Current Evidence and Clinical Considerations with Stephanie Gold

Moderated by Nazia Selzner and Chadwick Williams

• Post Operative Medical Care Therapy: Risk Stratification vs Treatment for all argued by Karen Kroeker and John Marshall
• Transplant More or Transplant Less: Expanding Criteria for Transplant in Liver Disease argued by Aldo Montano-Loza and Cynthia Tsien

Moderated by Adriana Lazarescu and David Rodrigues

• Biofeedback/Breathing with Jordi Serra
• Use of Antibiotics with Paul Moyyaedi
• Management of Constipation with Christopher Andrews

Moderated by Tae-Hee Kim & Alex Gregorieff

• Gastric stem cells, regeneration and cancer with Michael Sigal
• Understanding disease pathogenesis to drive drug discovery for H. pylori infection with Nicola Jones
• Esophageal tumor microenvironment with Lorenzo Ferri
• ABSTRACT: BAF Complex Recruits Lineage-Specific Transcription Factors to Terminate Gastric Regeneration and Prevent Cancer with Adrian Loe

Moderated by Simone Kortbeek and Veronique Morinville

• Bringing Healthcare into the Kitchen: Harnessing the Power of Food as Medicine with Debora Duro
• Development of a Culinary Medicine Program - University of Toronto Experience with Christopher Tomlinson
• Plate to Patient: Modulating the Microbiome in Gastrointestinal Disease with Nikhil Pai

Moderated by Stephanie Carpentier and Melissa Kelley 

• Diagnostics at the Gut-Liver Interface with Mark Swain 
• MASLD and IBS/IBD: Overlapping Patient Populations, Diverging Strategies with Giada Sebastiani
• Multidisciplinary Approaches in Transplant Programs for Metabolically dysregulated-associated Steatohepatitis with Nazia Selzner

Hosted by Lawrence Hookey

• Presentation of CAG Fellowship Awards
• McKenna Lecture on Colorectal Cancer Screening: Progress and Potential by Linda Rabeneck

Moderated by Genelle Lunken and Lisa Reynolds

• The mycobiome in IBD and Inflammation with Iliyan Iliev
• Helminths as a source of therapeutics for IBD with Derek McKay
• Viruses in Gut Health with Katharina Lahl

Moderated by Kathryn Woodman & Louis Liu

• ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis (2025) with Milli Gupta
• ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis (2025) with Colleen Parker
• AGA Clinical Practice Guideline on Management of Gastroparesis (2025) with Christopher Andrews
• AGA Clinical Practice Guideline on Management of Gastroparesis (2025) with Dan Sadowski
• AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review (2025) with Yvonne Tse
• AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review (2025) with Laurence Guay

Tickets available for purchase via the registration portal.

Moderated by Carolina Tropini and Elena Verdu

• The small bowel as a key immune organ with Andrew MacPherson
• Studying the small intestinal microbiome: gaps, opportunities and implications for food sensitivities with Alberto Caminero
• Culture-enriched molecular profiling of the duodenal microbiome and potential role in host metabolic function in healthy and prediabetic subjects with Andre Marette

Moderated by Milli Gupta and Matt Miles

• Achalasia and other Esophageal motor disorders underlying dysphagia with Louis Liu
• Measure twice, cut once: POEM vs. Surgery with Neal Shahidi

Moderated by Desmond Leddin and Harminder Singh

• The impact of environmental change on digestive health and digestive healthcare on the environment with Paul Moayyedi
• Carbon and environmental footprint of GI endoscopy with Heiko Pohl
• CAG-ASGE quality improvement program for sustainable endoscopy with Neal Shahidi
• Cost savings of going green. Can we save the environment while saving money? with Desmond Leddin

Panel

• Adult Perspective with Frances Tse
• Pediatrics Perspective with Natasha Lepore

Moderated by Charles Bernstein and Yasmin Nasser

• Brain/Gut Axis in IBD with Charles Bernstein
• Yoga - an effective tool for disorders of gut-brain interaction with Yasmin Nasser
• Neuroimaging correlates of depression and anxiety in IBD with Jennifer Kornelsen
• ABSTRACT: Systems-level Pathway Mapping Reveals Gut–Brain and Immune Signatures in Flares of IBS with Vidhyalakshmi Mohan

Moderated by Juan Abraldes and Angela Crawley

• Global Perspectives on MASLD: Epidemiology, Challenges, and Future Directions with Ming-Hua Zheng 
• Unraveling the Natural History of MASLD: The Interplay of Genetics, Sex, and Ethnicity with Luca Valenti 
• Sex considerations in animal and experimental models of MASLD with Angela Crawley
• ABSTRACT: Dynamic Steatotic Liver Disease Classifications: A Descriptive Analysis of the Canadian Longitudinal Study of Aging with Carmela Rapino

Hosted by Ikram Abow-Mohamed & Farah Albader

• Introduction & overview of fibroscan
• Hands on application - liver & spleen 
• Interactive case discussions

Moderated by James Kim and Elizabeth Lee 

• Non-invasive biomarkers for risk stratification with Keyur Patel
• Innovations in MASLD Imaging and artificial intelligence Integration with Mamatha Bhat
• Integrating Sex and Gender in Models of Health Delivery for MASLD with Saumya Jayakumar 
• ABSTRACT: Spatial Transcriptomics Reveals Sex-Specific Molecular Zonation Signatures in F2 Masld Fibrotic Livers with Henry Nguyen

Moderated by Mohit Kehar and Cindy Wen

• Understanding and Addressing MASLD Disparities in LGBTQ+ Communities with Tzu-Hao "Howard" Lee
• Epidemiological Insights into MASLD in the Canadian Diverse Population with Sahar Saeed 
• Introducing a White Paper on Liver disease in Gender-Diverse and Sexual Minority Populations with Duy Dinh
• FIB-4 Risk Stratification Model Can Predict Liver-Related Outcomes of MASLD Patients Receiving Care in Non-Specialty/Primary Care Settings with Sam Esfandiari

Moderated by Clara Long and Alnoor Ramji

• Gender-Sensitive Lifestyle Approaches to MASLD with Giada Sebastiani
• Incretin-based Therapy for MASLD with Harpreet Bajaj 
• MASH-targeted Therapy for MASLD with Mark Swain
• ABSTRACT: Non-Invasive Two-Step Triage Reduces Access Delays to Liver Services for People with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Tertiary Program Evaluation with Yasamin Farbod

Hosted by Ikram Abow-Mohamed & Farah Albader

• Introduction & overview of fibroscan
• Hands on application - liver & spleen 
• Interactive case discussions

Moderated by Che Colpitts and Justin Presseau

Opening Remarks with Che Colpitts and Justin Presseau

• New Horizons in HCV Prevention, in Canada and Globally with Jason Grebely
• Has 'treatment as prevention' delivered on its promise? with Natasha Martin
• Q&A 
• ABSTRACT: Montréal Sans HépC: Eliminating Hepatitis C Virus in Montreal Through a Community Focused, Population-Tailored, Multi-Pronged Approach with James O'Grady
• ABSTRACT: Adapting and Pivoting: Transforming Micro-Elimination  Within a Nurse-Led Hepatitis C Treatment Program in Victoria, B.C. with Tamara Barnett

Hosted by Ikram Abow-Mohamed & Farah Albader

• Introduction & overview of fibroscan
• Hands on application - liver & spleen 
• Interactive case discussions

Moderated by Rivka Kushner

CanHepC Panel: Harm Reduction & HCV Prevention (facilitated by CATIE) with Jason Altenberg, Ahmed Bayoumi, Douglas Belanger, Barb Fornssler, Martin Pagé

• ABSTRACT: Sex-Specific Patterns of Cardiometabolic and Renal Complications by Ethnicity Among People with Hepatitis C in British Columbia, Canada: A Population-Based Study with Dahn Jeong
• ABSTRACT: Infusing Personal Perspective and Experience in Contextualizing and Strategizing HCV Care with First Nation People with Ciara Eizadirad

Moderated by Nadine Kronfli

• Canada's successes and failures in HCV prevention with PWUD/PWID with Julie Bruneau
• Q&A
• ABSTRACT: Perspectives on Hepatitis C Self- Testing Among First Nations Populations in Ontario with Kate Dunn
• ABSTRACT: Acceptability of Dried Blood Spot Testing for Hepatitis C Virus and Other Bloodborne and Sexually Transmitted Infections Among People Incarcerated in Quebec Provincial Prisons with Olivia Price
• ABSTRACT: Increasing Burden of Syphilis Among People with Hepatitis C in British Columbia with Sofia Bartlett

Moderated by Che Colpitts

• Pipeline for B-cell based HCV vaccines with Justin Bailey
• Pipeline for T-cell based HCV vaccines with Naglaa Shoukry
• Q&A
• ABSTRACT: Single-Cell RNA Sequencing Reveals Il-32-Expressing Cd8 T Cells and Mait Cells as Distinctive Features of Spontaneous Resolution During HCV Reinfection with Nicol Flores
• ABSTRACT: Characterizing the Escape Barrier of Vaccine-Induced Antisera Against Hepatitis C Virus with Farnaz Aligolighasemabadi

Hosted by Ikram Abow-Mohamed & Farah Albader

• Introduction & overview of fibroscan
• Hands on application - liver & spleen 
• Interactive case discussions

Moderated by Jordan Feld

• Lessons learned from HCV vaccine trials with Kim Page
• Why participate in an HCV controlled human infection model? with Paul Zimmer-Harwood
• Ethics of Controlled Human Infection Modelling with Charles Weijer
• Building Confidence in Vaccinations in Diverse Populations with Eve Dube
• Q&A

Closing remarks by Che Colpitts and Justin Presseau

Moderated by Cynthia Tsien

• Long-term post transplant complications with Rahima Banji
• Oncology & liver transplant with Arndt Vogel
• Equity policies with Tzu-Hao "Howard" Lee 
• AI in Transplant with Mamatha Bhat 
• Living Donor in High Meld and Oncology Patients with Nazia Selzner

Moderated by Che Colpitts and Justin Presseau

Opening Remarks with Che Colpitts and Justin Presseau

• New Horizons in HCV Prevention, in Canada and Globally with Jason Grebely
• Has 'treatment as prevention' delivered on its promise? with Natasha Martin
• Q&A 
• ABSTRACT: Montréal Sans HépC: Eliminating Hepatitis C Virus in Montreal Through a Community Focused, Population-Tailored, Multi-Pronged Approach with James O'Grady
• ABSTRACT: Adapting and Pivoting: Transforming Micro-Elimination  Within a Nurse-Led Hepatitis C Treatment Program in Victoria, B.C. with Tamara Barnett

Hosted by Ikram Abow-Mohamed & Farah Albader

• Introduction & overview of fibroscan
• Hands on application - liver & spleen 
• Interactive case discussions

Moderated by Juan Abraldes and Angela Crawley

• Global Perspectives on MASLD: Epidemiology, Challenges, and Future Directions with Ming-Hua Zheng 
• Unraveling the Natural History of MASLD: The Interplay of Genetics, Sex, and Ethnicity with Luca Valenti 
• Sex considerations in animal and experimental models of MASLD with Angela Crawley
• ABSTRACT: Dynamic Steatotic Liver Disease Classifications: A Descriptive Analysis of the Canadian Longitudinal Study of Aging with Carmela Rapino

Moderated by Rivka Kushner

CanHepC Panel: Harm Reduction & HCV Prevention (facilitated by CATIE) with Jason Altenberg, Ahmed Bayoumi, Douglas Belanger, Barb Fornssler, Martin Pagé

• ABSTRACT: Sex-Specific Patterns of Cardiometabolic and Renal Complications by Ethnicity Among People with Hepatitis C in British Columbia, Canada: A Population-Based Study with Dahn Jeong
• ABSTRACT: Infusing Personal Perspective and Experience in Contextualizing and Strategizing HCV Care with First Nation People with Ciara Eizadirad

Opening Greetings by Carla Coffin and Giada Sebastiani

Welcome Ceremony and Blessing by Elder Lori Lamarche Boros

Presentation of Education Awards by Mayur Brahmania & Aldo Montano-Loza

• CASL- Liver Canada Visiting Professorship
  Scott Fung
   
• 2026-2027 CASL Clinical Hepatology Fellowship Award
  Louis Huynh 
   
• CASL Education Excellence Award
  Hin Hin Ko

Presentation of Research Awards by Christopher Rose & Mamatha Bhat

• CASL Research Excellence Award
  Jordan Feld
   
• CASL Travel Grant Awards
  Poshika Dhingra and Yvette Ysabel Yao 

Presentation of Collaborative Awards Giada Sebastiani

• CMDO Network Competition Winner
  Matthieu Lepage
   
• Baveno Consensus Workshop Collaboration Grant
  Clara Long

Presentation of CIHR-INMD-CASL Prize by Christopher Rose, Mamatha Bhat, and Mary Jung

• CIHR-INMD-CASL Early Career Researcher Partnership Award
  Daljeet Chahal

Presentation of PSC Partners Seeking a Cure Award by Christopher Rose, Mamatha Bhat, and Mary Pressley Vyas

• PSC Partners Seeking a Cure Award 
  Natassia Tan

Presentation of Distinguished Service Award by Carla Coffin & Ed Tam

• CASL Distinguished Service Award
  Stephen Wong

CASL-Liver Canada Gold Medal Introduction by Carla Coffin & Jennifer Nebesky 

Presentation of CASL-Liver Canada Gold Medal Winner by Kelly Burak

• CASL-Liver Canada Gold Medal Recipient Lecture
  Ray Kim

Moderated by James Kim and Elizabeth Lee 

• Non-invasive biomarkers for risk stratification with Keyur Patel
• Innovations in MASLD Imaging and artificial intelligence Integration with Mamatha Bhat
• Integrating Sex and Gender in Models of Health Delivery for MASLD with Saumya Jayakumar 
• ABSTRACT: Spatial Transcriptomics Reveals Sex-Specific Molecular Zonation Signatures in F2 Masld Fibrotic Livers with Henry Nguyen

Moderated by Curtis Cooper

• Lab Testing with Emma Lee
• Screening for HBV + HDV with Hin Hin Ko
• Expanded Treatment Indication with Scott Fung 
• Viral Co-Infection: HCV/ HDV/HIV with Curtis Cooper
• Pediatric HBV with Fernando Alvarez

Moderated by Nadine Kronfli

• Canada's successes and failures in HCV prevention with PWUD/PWID with Julie Bruneau
• Q&A
• ABSTRACT: Perspectives on Hepatitis C Self- Testing Among First Nations Populations in Ontario with Kate Dunn
• ABSTRACT: Acceptability of Dried Blood Spot Testing for Hepatitis C Virus and Other Bloodborne and Sexually Transmitted Infections Among People Incarcerated in Quebec Provincial Prisons with Olivia Price
• ABSTRACT: Increasing Burden of Syphilis Among People with Hepatitis C in British Columbia with Sofia Bartlett

Moderated by Mohit Kehar and Cindy Wen

• Understanding and Addressing MASLD Disparities in LGBTQ+ Communities with Tzu-Hao "Howard" Lee
• Epidemiological Insights into MASLD in the Canadian Diverse Population with Sahar Saeed 
• Introducing a White Paper on Liver disease in Gender-Diverse and Sexual Minority Populations with Duy Dinh
• FIB-4 Risk Stratification Model Can Predict Liver-Related Outcomes of MASLD Patients Receiving Care in Non-Specialty/Primary Care Settings with Sam Esfandiari

Moderated by Scott Fung and Emma Lee 

• Strengthening Diagnostic Pathways Through Collaboration Between Medical Microbiologists and Clinicians; Insight from Collaborative Workshop with Christopher Lowe
• Optimizing Hepatitis B Monitoring in Ontario: Implementation and Availability of Quantitative HBsAg Testing with Tony Mazzulli
• Clinical Value of Quantitative HBsAg Testing in Hepatitis B Care with Stephen Congly
• Panel Discussion with Tianyan Chen, Curtis Cooper and Julian Hercun

Moderated by Nazia Selzner and Chadwick Williams

• Post Operative Medical Care Therapy: Risk Stratification vs Treatment for all argued by Karen Kroeker and John Marshall
• Transplant More or Transplant Less: Expanding Criteria for Transplant in Liver Disease argued by Aldo Montano-Loza and Cynthia Tsien

Moderated by Clara Long and Alnoor Ramji

• Gender-Sensitive Lifestyle Approaches to MASLD with Giada Sebastiani
• Incretin-based Therapy for MASLD with Harpreet Bajaj 
• MASH-targeted Therapy for MASLD with Mark Swain
• ABSTRACT: Non-Invasive Two-Step Triage Reduces Access Delays to Liver Services for People with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Tertiary Program Evaluation with Yasamin Farbod

Moderated by Che Colpitts

• Pipeline for B-cell based HCV vaccines with Justin Bailey
• Pipeline for T-cell based HCV vaccines with Naglaa Shoukry
• Q&A
• ABSTRACT: Single-Cell RNA Sequencing Reveals Il-32-Expressing Cd8 T Cells and Mait Cells as Distinctive Features of Spontaneous Resolution During HCV Reinfection with Nicol Flores
• ABSTRACT: Characterizing the Escape Barrier of Vaccine-Induced Antisera Against Hepatitis C Virus with Farnaz Aligolighasemabadi

Hosted by Ikram Abow-Mohamed & Farah Albader

• Introduction & overview of fibroscan
• Hands on application - liver & spleen 
• Interactive case discussions

Moderated by Marc Bilodeau and Tianyan Chen

• MASLD with Giada Sebastiani
• Portal hypertension with Amine Benmassaoud
• Hepatitis B with Julian Hercun
• Identification de nouveaux substrats de TMPRSS6, une protéase hépatique émergente dans la MASLD (Identification of novel substrates of TMPRSS6, an emerging hepatic protease in MASLD) with Matthieu Lepage

Moderated by Jordan Feld

• Lessons learned from HCV vaccine trials with Kim Page
• Why participate in an HCV controlled human infection model? with Paul Zimmer-Harwood
• Ethics of Controlled Human Infection Modelling with Charles Weijer
• Building Confidence in Vaccinations in Diverse Populations with Eve Dube
• Q&A

Closing remarks by Che Colpitts and Justin Presseau

Moderated by Stephanie Carpentier and Melissa Kelley 

• Diagnostics at the Gut-Liver Interface with Mark Swain 
• MASLD and IBS/IBD: Overlapping Patient Populations, Diverging Strategies with Giada Sebastiani
• Multidisciplinary Approaches in Transplant Programs for Metabolically dysregulated-associated Steatohepatitis with Nazia Selzner

Moderated by Aldo Montano-Loza

• Current status of treatment for PSC with Palak Trivedi 
• IgG4 hepatobiliry and biliary disease with Emma Culver 
• New treatments for PBC with Gideon Hirschfield
• Gaps of treatment and diagnosis in autoimmune hepatitis with Ye Htun Oo
• Gut liver axis in PSC with Palak Trivedi 

Moderated by Orlee Guttman

• Infantile and congenital hepatic hemangiomata with Leticia Khendek
• Surgical considerations in hepatoblastoma with Nicolas Goldaracena
• Hydatid Liver Cysts with Estelle Morin
• Interventional Radiology and the Hepatic Mass with Antonio Hernandez Villegas

Moderated by Tasha Kulai and Fernanda Onofrio

• ALD pharmacotherapy: targeting inflammation, gut-liver signaling and fibrosis with Suthat Liangpunsakul
• Sex, hormones and susceptibility: understanding why women are developing ALD faster with Jennifer Flemming
• Liver Transplantation for ALD: navigating controversy, complexity, and change with Nazia Selzner
• Turning evidence into action: alcohol policy and its implications on liver health with Juan Pablo Arab
• Alcohol-Associated Liver Disease: Transforming Lived Experience into Liver Health Advocacy with Vanessa Wojtala

This is an opportunity for members to have your say, hear updates and about accomplishments from 2025, discuss priorities for 2026, and take part in member business including voting on the next president-elect.

Tickets available for purchase via the registration portal.

Moderated by Angela Crawley and Adam Gehring

• Treg biology in chronic autoimmune liver disease with Ye Htun Oo
• Single cell profiling of Tregs with Sonya Macparland 
• Engineering antigen‐specific Tregs for targeted tolerance in transplantation or Clinical‐translational challenges / early human data with Elmar Jaeckel 

Moderated by Vladimir Marquez

• Introduction / Launch of Canadian Hepatitis B Peer Support Group with Colina Yim and Hin Hin Ko
• To Advance Research in Cis & Trans Diverse Minority Communities with Duy Dinh
• Research and connection with Indigenous communities with Kate Dunn
• Panel on Building CASL and AASLD joint community advocacy with Tzu-Hao (Howard) Lee

Moderated by Scott Fung and Erin Kelly

• Trends in Alcohol Hepatitis with Juan Pablo Arab 
• Universal Infant Vaccination for HBV with Carla Coffin
• Obesity in Children with Mohit Kehar
• Public Health and MASLD/MASH with Giada Sebastiani

Moderated by Mamatha Bhat and Christopher Rose

• ABSTRACT: Predictors of Inadequate Protein Intake and Malnutrition in Patients with Cirrhosis with Poshika Dhingra
• ABSTRACT: Immune Failure as Part of the Acute-On-Chronic Liver Failure Syndrome in Hospitalised Patients with Decompensated Cirrhosis with Niamh Mehigan Farrelly
• ABSTRACT: TREM2⁺ Macrophage Persistence, Location and Efferocytosis-Induced Activation in Aggressive Cases of Hepatocellular Carcinoma with Ariya Shiwram
• ABSTRACT: Generation of Patient-Derived Human Liver Organoids from Fresh and Cryopreserved Human Liver Homogenate with Michelle Sue
• ABSTRACT: Higher One Year Graft Failure in Donation After Circulatory Death (DCD) vs Donation After Brain Death (DBD) Liver Transplantation in Acute-On-Chronic Liver Failure (ACLF) with Yvette Ysabel Yao